Overweight and obesity significantly increase colorectal cancer risk: a meta-analysis of 66 studies revealing a 25–57% elevation in risk

Ungvari, Zoltan [Ungvári, Zoltán István (Orvostudomány, él...), szerző] Megelőző Orvostani és Népegészségtani Intézet (SE / AOK / I); Fekete, Mónika [Fekete, Mónika (Népegészségtan), szerző] Megelőző Orvostani és Népegészségtani Intézet (SE / AOK / I); Varga, Peter [Varga, Péter (foglalkozás-orvostan), szerző] Megelőző Orvostani és Népegészségtani Intézet (SE / AOK / I); Lehoczki, Andrea [Lehoczki, Andrea Marianna (hematológia, belg...), szerző] Megelőző Orvostani és Népegészségtani Intézet (SE / AOK / I); Fekete, János Tibor [Fekete, János Tibor (PhD), szerző] Bioinformatika Tanszék (SE / AOK / I); Onkológiai Biomarker Kutatócsoport (Lendület) (HRN TTK / MÉI); Ungvari, Anna ✉ [Ungvári, Anna Sára (népegészségtan), szerző] Megelőző Orvostani és Népegészségtani Intézet (SE / AOK / I); Győrffy, Balázs [Győrffy, Balázs (Onkológia), szerző] Bioinformatika Tanszék (SE / AOK / I); Onkológiai Biomarker Kutatócsoport (Lendület) (HRN TTK / MÉI); Biofizikai Intézet (PTE / ÁOK)

Angol nyelvű Szakcikk (Folyóiratcikk) Tudományos
  • SJR Scopus - Complementary and Alternative Medicine: D1
Azonosítók
Támogatások:
  • (TKP2021-NKTA-47)
  • Nemzeti Kardiovaszkuláris Laboratórium(RRF-2.3.1-21-2022-00003) Támogató: NKFIH
  • Nemzeti Gyógyszerkutatási és Fejlesztési Laboratórium (PharmaLab)(RRF-2.3.1-21-2022-00015) Támogató: NKFIH
  • (101004093/EUniWell/EAC-A02- 2019/EAC-A02-2019-1)
The incidence of colorectal cancer (CRC) has been steadily rising, and obesity has been identified as a significant risk factor. Numerous studies suggest a strong correlation between excess body weight and increased risk of CRC, but comprehensive quantification through pooled analysis remains limited. This study aims to systematically review and meta-analyze the existing literature to evaluate the association between obesity and CRC risk, considering variations across sex and study designs. A systematic literature search was conducted in PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science to identify randomized controlled trials and human clinical trials from 1992 to 2024. Statistical analysis was performed using the https://metaanalysisonline.com web application using a random effects model to estimate the pooled hazard rates (HR). Forest plots, funnel plots, and Z-score plots were utilized to visualize results. We identified 52 clinical trials and 14 case–control studies, encompassing a total of 83,251,050 and 236,877 subjects, respectively. The pooled analysis indicated that obesity significantly increased the prevalence of CRC (HR = 1.36, 95% CI = 1.24–1.48, p < 0.01). This effect was consistent across sexes, with HRs of 1.57 (95% CI = 1.38–1.78, p = 0.01) for males and 1.25 (95% CI = 1.14–1.38, p < 0.01) for females. Case–control studies specifically showed an effect, but with marginal significance only (HR = 1.27, 95% CI = 0.98–1.65, p = 0.07). The Z-score plot indicated the need for additional analysis in the case–control group. A significant heterogeneity was observed across studies in all four settings. This meta-analysis provides robust evidence that obesity is a significant risk factor for colorectal cancer, with an overall hazard rate indicating a 36% increased risk. The effect is pronounced across both sexes, with males showing a slightly higher risk compared to females. Although case–control studies showed a weaker association, the overall trend supports the link between obesity and CRC. These results underscore the importance of public health interventions aimed at reducing obesity to potentially lower the risk of colorectal cancer.
Hivatkozás stílusok: IEEEACMAPAChicagoHarvardCSLMásolásNyomtatás
2024-12-09 14:13